Schmidt, Warren N.

Publishing since 1994 (Senior)

Has published 29 publications in 17 years

Number of publications published per year by Schmidt, Warren N.. (Source : PubMed)

Distribution of publications types for Schmidt, Warren N.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Zhu Z, Wilson AT, Gopalakrishna K, Brown KE, Luxon BA, Schmidt WN. Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells.  J. Med. Virol.  2010;82;2  
•  Ali S, Stolpen AH, Schmidt WN. Portosystemic Encephalopathy due to Mesoiliac Shunt in a Patient Without Cirrhosis.  J. Clin. Gastroenterol.  2009  
•  Kayali Z, Herring J, Baron P, Franco E, Ojogho O, Smith J, Watkins G, Smith D, Lamin V, Hoang T, Sharma R, Mathahs M, Sowers L, Brown KE, Schmidt WN. Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction.  J. Gastroenterol. Hepatol.  2009;24;6  
•  Bergmann OM, Mathahs MM, Broadhurst KA, Weydert JA, Wilkinson N, Howe JR, Han O, Schmidt WN, Brown KE. Altered expression of iron regulatory genes in cirrhotic human livers: clues to the cause of hemosiderosis?  Lab. Invest.  2008;88;12  
•  Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, Schmidt WN. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.  Hepatology  2008;48;5  
•  Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.  Transplantation  2007;84;3  
•  Hu KQ, Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, McCracken JD, Morgan T, Bräu N, Schmidt WN, Jeffers L, Wright TL. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.  Dig. Dis. Sci.  2007;52;2  
•  Kayali Z, Tan S, Shinkunas L, Voigt M, LaBrecque DR, Stapleton JT, Brown KE, Schmidt WN. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.  J. Viral Hepat.  2007;14;1  
•  Bräu N, Bini EJ, Currie S, Shen H, Schmidt WN, King PD, Ho SB, Cheung RC, Hu KQ, Anand BS, Simon FR, Aytaman A, Johnson DP, Awad JA, Ahmad J, Mendenhall CL, Pedrosa MC, Moseley RH, Hagedorn CH, Waters B, Chang KM, Morgan TR, Rossi SJ, Jeffers LJ, Wright TL. Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.  J. Viral Hepat.  2006;13;4  
•  Kayali Z, Labrecque DR, Schmidt WN. Treatment of hepatitis C cryoglobulinemia: mission and challenges.  Curr Treat Options Gastroenterol  2006;9;6  

[ See timeline ] [ See all publications ]